Li, J., Wang, X., Xu, S., Zeng, D., Yang, Y. (2025). Transition to ixazomib-based maintenance following daratumumab-based induction for continuous therapy in newly diagnosed multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-7517